OA09419A - Dérivés de l'acide 3-pyrrolidinylthio-1-azabicyclo (3.2.0.) -hept-2-ene-2-carboxylique et leur préparation. - Google Patents

Dérivés de l'acide 3-pyrrolidinylthio-1-azabicyclo (3.2.0.) -hept-2-ene-2-carboxylique et leur préparation.

Info

Publication number
OA09419A
OA09419A OA59575A OA59575A OA09419A OA 09419 A OA09419 A OA 09419A OA 59575 A OA59575 A OA 59575A OA 59575 A OA59575 A OA 59575A OA 09419 A OA09419 A OA 09419A
Authority
OA
OAPI
Prior art keywords
pyrrolidinylthio
azabicyclo
hept
ene
preparation
Prior art date
Application number
OA59575A
Other languages
English (en)
Inventor
Masayoshi Murata
Hideo Tsutsumi
Keiji Matsuda
Takaashi Nakajima
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of OA09419A publication Critical patent/OA09419A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12—Oxygen or sulfur atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
OA59575A 1988-05-12 1989-05-12 Dérivés de l'acide 3-pyrrolidinylthio-1-azabicyclo (3.2.0.) -hept-2-ene-2-carboxylique et leur préparation. OA09419A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888811237A GB8811237D0 (en) 1988-05-12 1988-05-12 3-pyrrolidinylthio-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives

Publications (1)

Publication Number Publication Date
OA09419A true OA09419A (fr) 1992-10-15

Family

ID=10636779

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59575A OA09419A (fr) 1988-05-12 1989-05-12 Dérivés de l'acide 3-pyrrolidinylthio-1-azabicyclo (3.2.0.) -hept-2-ene-2-carboxylique et leur préparation.

Country Status (16)

Country Link
US (1) US4983596A (fr)
EP (1) EP0341557A1 (fr)
JP (1) JPH02204490A (fr)
CN (1) CN1038645A (fr)
AU (1) AU3402289A (fr)
DK (1) DK230689A (fr)
FI (1) FI892281A (fr)
GB (1) GB8811237D0 (fr)
HU (1) HU208013B (fr)
IL (1) IL90191A0 (fr)
MX (1) MX15990A (fr)
NO (1) NO168825C (fr)
NZ (1) NZ229071A (fr)
OA (1) OA09419A (fr)
PT (1) PT90527A (fr)
ZA (1) ZA893479B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8923844D0 (en) * 1989-10-23 1989-12-13 Fujisawa Pharmaceutical Co Carbapenem compounds
GB9103034D0 (en) * 1991-02-13 1991-03-27 Fujisawa Pharmaceutical Co Processes for preparing carbapenem derivatives
US5360798A (en) * 1991-07-04 1994-11-01 Shionogi Seiyaku Kabushiki Kaisha Aminooxypyrrolidinylthiocarbapenem compounds
AU3904493A (en) * 1992-04-13 1993-11-18 Fujisawa Pharmaceutical Co., Ltd. Substituted 3-pyrrolidinylthio-carbapenems as antimicrobial agents

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4552873A (en) * 1981-08-19 1985-11-12 Sankyo Company Limited Carbapenem compounds, and compositions containing them
JPS5916892A (ja) * 1982-07-19 1984-01-28 Sankyo Co Ltd カルバペネム−３−カルボン酸誘導体およびその製法
KR900006449B1 (ko) * 1982-08-24 1990-08-31 상꾜 가부시끼가이샤 아제티디논 화합물의 제조방법
CA1283906C (fr) * 1983-05-09 1991-05-07 Makoto Sunagawa COMPOSE DE .beta.-LACTAM ET PROCEDE DE PRODUCTION
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd １―置換カルバペネム―３―カルボン酸誘導体
DE3579888D1 (de) * 1984-11-08 1990-10-31 Sumitomo Pharma Carbapenemverbindungen und deren herstellung.
DE3780344T2 (de) * 1986-03-27 1993-01-28 Sumitomo Pharma Beta-lactam-verbindungen und deren herstellung.
KR880006244A (ko) * 1986-11-24 1988-07-22 후지사와 도모 기찌 로 3-피롤리디닐티오-1-아자바이스클로[3.2.0]햅트2-엔-2-카르복실산 화합물 및 이의 제조방법

Also Published As

Publication number Publication date
AU3402289A (en) 1989-11-16
HUT50476A (en) 1990-02-28
EP0341557A1 (fr) 1989-11-15
NO891919D0 (no) 1989-05-11
JPH02204490A (ja) 1990-08-14
DK230689A (da) 1989-11-13
NZ229071A (en) 1990-08-28
NO891919L (no) 1989-11-13
FI892281A0 (fi) 1989-05-11
US4983596A (en) 1991-01-08
HU208013B (en) 1993-07-28
NO168825C (no) 1992-04-08
GB8811237D0 (en) 1988-06-15
MX15990A (es) 1993-09-01
PT90527A (pt) 1989-11-30
ZA893479B (en) 1990-01-31
NO168825B (no) 1991-12-30
CN1038645A (zh) 1990-01-10
FI892281A (fi) 1989-11-13
DK230689D0 (da) 1989-05-11
IL90191A0 (en) 1989-12-15

Similar Documents

Publication Publication Date Title
MC1881A1 (fr) Derives de l'acide phosphinique
OA08694A (fr) Acides 3-pyrrolidinylthio-1-azabicyclo [3.2.0] -hept-2-ène-2-carboxyliques et procédés pour leur préparation.
PT84230A (pt) Carrinho de crianca de berco basculante
OA09847A (fr) dérivés d'epipodophyllotoxine altroside
DE3867086D1 (de) Benzothiepino(5,4-c)pyridazin-verbindungen und ihre pharmazeutischen wirkungen.
FR2506313B1 (fr) Derives de l'acide n-acetylneuraminique et leur preparation
OA09419A (fr) Dérivés de l'acide 3-pyrrolidinylthio-1-azabicyclo (3.2.0.) -hept-2-ene-2-carboxylique et leur préparation.
FR2630735B1 (fr) Procede de preparations d'halogenophenols
OA08746A (fr) Dérivés d'acide hydrocinnamique.
OA07270A (fr) Dérivés N-(vinblastinoyl-23) d'acide aminés, leur préparation et leur application thérapeutique.
DK702688D0 (da) Epipodophyllotoxin-glucosid 4'-acylderivater
OA07728A (fr) Dérivés de l'acide bicyclo (3.2.1.) octane carboxylique, leur procédé de préparation et leur application thérapeutique.
FR2689129B1 (fr) Nouveaux dérivés de l'acide 3-mercapto-2-thénoique et leurs procédés de préparation.
OA06526A (fr) Nouveaux dérivés halogénés de l'isopropylamino-pyrimidine et leur préparation.
OA06756A (fr) Nouveaux dérivés de l'amino-2 phénéthylamines et leur préparation.
NZ223138A (en) 2,1-benzothiazepine-2,2-dioxide-5-carboxylic acid derivatives and pharmaceutical compositions
FR2699921B1 (fr) Dérivés d'acide 2-(thien-2-yl)imidazo[2,1-b]benzothiazole-3-acétique, leur préparation et leur application en thérapeutique.
FR2600059B1 (fr) Derives de l'acide benzoique et leur procede de preparation
GR3002465T3 (en) Benzohydroxamic acid derivatives
FR2699175B1 (fr) Dérivés de la 2-iminoimidazolidine et leur préparation.
FR2655646B1 (fr) Procede de preparation de diesters de l'acide hexenediouique.
FR2646850B1 (fr) Derives d'acide dibenzo(b,e)thiepinne-3-acetique, leur preparation et leur application en therapeutique
FR2693194B1 (fr) Dérivés d'alcanecarboxamide, leur préparation et leur application thérapeutique.
OA06176A (fr) Dérivés d'acides phosphinique d'aminothio-méthyl-carbamates et leur préparation.
ES1001693Y (es) Braguita infantil mejorada